Platelet-derived chemokines CXC chemokine ligand (CXCL)7, connective tissue-activating peptide III, and CXCL4 differentially affect and cross-regulate neutrophil adhesion and transendothelial migration.
In this study, we have examined the major platelet-derived CXC chemokines connective tissue-activating peptide III (CTAP-III), its truncation product neutrophil-activating peptide 2 (CXC chemokine ligand 7 (CXCL7)), as well as the structurally related platelet factor 4 (CXCL4) for their impact on neutrophil adhesion to and transmigration through unstimulated vascular endothelium. Using monolayers of cultured HUVEC, we found all three chemokines to promote neutrophil adhesion, while only CXCL7 induced transmigration. Induction of cell adhesion following exposure to CTAP-III, a molecule to date described to lack neutrophil-stimulating capacity, depended on proteolytical conversion of the inactive chemokine into CXCL7 by neutrophils. This was evident from experiments in which inhibition of the CTAP-III-processing protease and simultaneous blockade of the CXCL7 high affinity receptor CXCR-2 led to complete abrogation of CTAP-III-mediated neutrophil adhesion. CXCL4 at substimulatory dosages modulated CTAP-III- as well as CXCL7-induced adhesion. Although cell adhesion following exposure to CTAP-III was drastically reduced, CXCL7-mediated adhesion underwent significant enhancement. Transendothelial migration of neutrophils in response to CXCL7 or IL-8 (CXCL8) was subject to modulation by CTAP-III, but not CXCL4, as seen by drastic desensitization of the migratory response of neutrophils pre-exposed to CTAP-III, which was paralleled by selective down-modulation of CXCR-2. Altogether our results demonstrate that there exist multiple interactions between platelet-derived chemokines in the regulation of neutrophil adhesion and transendothelial migration.
Department of Immunology and Cell Biology, Forschungszentrum Borstel, Borstel, Germany.
Birgit I
BI
Schenk
Frank
F
Petersen
Hans-Dieter
HD
Flad
Ernst
E
Brandt
D001792:Blood Platelets / Q000378:metabolism / Q000502:physiology*; D002448:Cell Adhesion / Q000502:physiology; D002465:Cell Movement / Q000502:physiology*; D002478:Cells, Cultured; D019743:Chemokines, CXC / Q000378:metabolism*; D018920:Coculture Techniques; D015536:Down-Regulation; D004730:Endothelium, Vascular / Q000166:cytology / Q000378:metabolism / Q000502:physiology*; D006801:Humans; D019041:L-Selectin / Q000502:physiology; D008024:Ligands; D016169:Lymphocyte Function-Associated Antigen-1 / Q000502:physiology; D016177:Macrophage-1 Antigen / Q000502:physiology; D020556:Neutrophil Infiltration / Q000502:physiology*; D010455:Peptides / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000502:physiology*; D010978:Platelet Factor 4 / Q000502:physiology*; D011498:Protein Precursors / Q000502:physiology; D023063:Receptors, Interleukin-8B / Q000502:physiology; D015854:Up-Regulation / Q000502:physiology; D001620:beta-Thromboglobulin
D019743:Chemokines, CXC; D008024:Ligands; D016169:Lymphocyte Function-Associated Antigen-1; D016177:Macrophage-1 Antigen; C061615:PPBP protein, human; D010455:Peptides; D011498:Protein Precursors; D023063:Receptors, Interleukin-8B; D001620:beta-Thromboglobulin; D019041:L-Selectin; D010978:Platelet Factor 4; C009862:connective tissue-activating peptide